Mhd R. Al Shweiki

Ulm, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Evidence for reduced synaptic protein SNAP-25 in cerebrospinal fluid in major depressive disorder and schizophrenia.

Evidence for reduced synaptic protein SNAP-25 in cerebrospinal fluid in major depressive disorder and schizophrenia.

Journal: BMJ mental health

Published: April 25, 2025

Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders.

Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders.

Journal: Journal of psychiatric research

Published: April 19, 2022

Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob Disease.

Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob Disease.

Journal: International journal of molecular sciences

Published: January 17, 2022

Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder.

Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder.

Journal: Journal of psychiatric research

Published: May 05, 2021

Reshaping of the Arabidopsis thaliana Proteome Landscape and Co-regulation of Proteins in Development and Immunity.

Reshaping of the Arabidopsis thaliana Proteome Landscape and Co-regulation of Proteins in Development and Immunity.

Journal: Molecular plant

Published: May 18, 2020

Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides are Decreased in Huntington's Disease.

Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides are Decreased in Huntington's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 27, 2020

Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion.

Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 21, 2019

S-ketamine induces acute changes in the proteome of the mouse amygdala.

S-ketamine induces acute changes in the proteome of the mouse amygdala.

Journal: Journal of proteomics

Published: November 10, 2019

Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder.

Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder.

Journal: Translational psychiatry

Published: October 14, 2019

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia.

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia.

Journal: Journal of psychiatric research

Published: February 14, 2019

Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.

Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.

Journal: Expert review of proteomics

Published: June 01, 2017

Assessment of Label-Free Quantification in Discovery Proteomics and Impact of Technological Factors and Natural Variability of Protein Abundance.

Assessment of Label-Free Quantification in Discovery Proteomics and Impact of Technological Factors and Natural Variability of Protein Abundance.

Journal: Journal of proteome research

Published: February 21, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026